Does Z52.3 require prior authorization?

No, Z52.3 does not require prior authorization (high confidence). Covered without prior authorization.

`Z52.3`, Bone marrow donor

ICD-10-CM

No Prior Auth Required

Covered without prior authorization (high confidence)

For services requiring a referring/ordering physician, the referring/ordering physician's name and NPI must be reported on the claim.
Diagnostic test claims should include the test result if known; if result is not available, report the symptoms that prompted the test.
The patient's medical record must include the ordering provider's assessment related to the visit complaint, relevant medical history, results of pertinent tests/procedures, and a signed and dated office visit record or operative report.
When using an Advance Beneficiary Notice of Non‑coverage (ABN) with modifier GA, the ABN Form CMS‑R‑131 must be signed by the beneficiary (or properly witnessed if refused) and Part A MAC claims require occurrence code 32 plus the ABN date.

CPT 88182 reports the physician professional and facility technical components of DNA ploidy and S-phase analysis of tumor by flow cytometry.
CPT 88184 (first marker) and CPT 88185 (each additional marker) report the facility technical component of flow cytometric immunophenotyping for assessment of potential hematolymphoid neoplasia.
Flow cytometry interpretation is reported using CPT codes 88187–88189 (one interpretation code per specimen).
Quantitative cell counts by flow cytometry are billed using CPT codes 86355, 86356, 86357, 86359, 86360, 86361, and 86367.
Flow cytometry services are payable under Medicare Part B at specified places of service according to CPT: groups of CPTs have defined allowable POS (see mapping in policy).
Compatibility testing of prospective donors who are close family members (first-degree relatives i.e., parents, siblings and children, or second-degree relatives i.e., grandparent, grandchild, uncle, aunt, nephew, niece, half-sibling) and harvesting and short-term storage of peripheral stem cells or bone marrow from the identified donor when an allogeneic bone marrow or peripheral stem cell transplant is authorized by Aetna.

CGS-J15-L34037, Flow Cytometry

J15

CGS-J18-L34037, Flow Cytometry

J18

AMBETTER-CG-Onc-Tumor-Hemat.-Malig.-2025.1, Concert Genetic Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies

CIGNA-0538, Flow Cytometry

AETNA-CPB-0190, Stem Cells for Hematopoietic Cell Transplant

Ask Backwork about documentation requirements, denial risks, or coverage in your state.